[{"uuid": "ff510c85-ff4d-3b93-b5d2-86afe282e59e", "title": "Why Compass Therapeutics Inc (CMPX) Is Skyrocketing So Far In 2025", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-compass-therapeutics-inc-cmpx-011505824.html", "providerPublishTime": 1738631705, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VxJVVTt0iwpXCLURN1uI1g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6c81e8b453b44050676190bef1cbe80f", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mzzRP_sy3nap1Kzc_sZ43g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6c81e8b453b44050676190bef1cbe80f", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "4914726d-3902-3b70-823c-e739fe9b7948", "title": "Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/compass-therapeutics-stock-skyrockets-108-162000718.html", "providerPublishTime": 1738340400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W5ve9LofNukkX0a38W9plQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "89fd912a-94d7-3629-ac7c-0b9cbe35b572", "title": "Compass Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/compass-therapeutics-participate-guggenheim-securities-130000492.html", "providerPublishTime": 1738155600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qKeTIyOjY0_yUEMCYoM_DA--~B/aD00ODQ7dz0xODYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 1861, "height": 484, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iwL1nwb7TmMtMRzY5.3mfg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMPX"]}, {"uuid": "4da4d3f6-a4aa-3b50-9427-1b4e64b543b7", "title": "Is Compass Therapeutics, Inc. (CMPX) the Hottest Smid-Cap Stock So Far In 2025?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/compass-therapeutics-inc-cmpx-hottest-130509471.html", "providerPublishTime": 1737551109, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VxJVVTt0iwpXCLURN1uI1g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6c81e8b453b44050676190bef1cbe80f", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mzzRP_sy3nap1Kzc_sZ43g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6c81e8b453b44050676190bef1cbe80f", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "4094fc61-0257-37a3-9872-61a13f3623b6", "title": "Dell Stock Set to Benefit From AI and Cloud Applications, Analyst Says. Plus, Twilio, Tradeweb, and More.", "publisher": "Barrons.com", "link": "https://finance.yahoo.com/m/4094fc61-0257-37a3-9872-61a13f3623b6/dell-stock-set-to-benefit.html", "providerPublishTime": 1736554320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_kc6REYMS1JrAuV5bYtjfA--~B/aD02NTt3PTMyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 320, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5waH37HKuL3X52B3V2GWrw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DELL", "TW", "TWLO"]}, {"uuid": "88d67455-21d3-300f-8370-ec30a51c15f7", "title": "Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/compass-therapeutics-provides-corporate-announces-130000636.html", "providerPublishTime": 1736341200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qKeTIyOjY0_yUEMCYoM_DA--~B/aD00ODQ7dz0xODYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 1861, "height": 484, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iwL1nwb7TmMtMRzY5.3mfg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMPX"]}, {"uuid": "cbd8edfe-cf70-3c50-8241-166cfb87cc9d", "title": "US Penny Stocks To Watch In January 2025", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/us-penny-stocks-watch-january-170814849.html", "providerPublishTime": 1736269694, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GFAI", "GFAIW", "IMAB", "CMPX"]}, {"uuid": "14edbfb9-5231-33b1-a53c-9d8a183be7a8", "title": "Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/compass-therapeutics-inc-cmpx-stock-144010072.html", "providerPublishTime": 1733841610, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wXNaNKXxuWlbebD.cUCv9g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.p9MEYX1wv8e0A4gfeMmAQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "46a26a94-de9e-3e8d-8f4e-d11e74f69242", "title": "Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/down-23-46-4-weeks-143506394.html", "providerPublishTime": 1732199706, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85", "width": 900, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ml_IW6uskjsyNFznUfnUDA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "c090f5d7-8abf-3eac-91c8-91c0db3d3f5d", "title": "What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/makes-compass-therapeutics-inc-cmpx-170010760.html", "providerPublishTime": 1731690010, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Em_DrzACdMhzlbouRNIMyA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "ed78c1e0-d5a0-3b33-b279-54b49029499b", "title": "Compass Therapeutics Names Barry Shin CFO", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/compass-therapeutics-names-barry-shin-154814496.html", "providerPublishTime": 1733845694, "type": "STORY"}, {"uuid": "8cdd4372-2065-38d9-8cf6-b43bac859979", "title": "Compass Therapeutics Appoints Biopharmaceutical Industry Leader\u00a0Barry Shin as Chief Financial Officer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/compass-therapeutics-appoints-biopharmaceutical-industry-130000756.html", "providerPublishTime": 1733835600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qKeTIyOjY0_yUEMCYoM_DA--~B/aD00ODQ7dz0xODYxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 1861, "height": 484, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iwL1nwb7TmMtMRzY5.3mfg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/341f01a47715d2784525420d19a1e21b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMPX"]}]